|
Volumn 49, Issue 7, 2000, Pages 634-637
|
Durability of improvement achieved in a clinical trial: Is compliance an issue?
a a a |
Author keywords
Blood pressure; Clinical trials; Professional practice
|
Indexed keywords
ANTIHYPERTENSIVE AGENT;
PLACEBO;
ADULT;
AMBULATORY MONITORING;
ARTICLE;
BLOOD PRESSURE MONITORING;
CLINICAL ARTICLE;
CLINICAL PRACTICE;
CLINICAL TRIAL;
FOLLOW UP;
HUMAN;
HYPERTENSION;
MALE;
PATIENT COMPLIANCE;
PROFESSIONAL PRACTICE;
ADULT;
ANTIHYPERTENSIVE AGENTS;
ATENOLOL;
BLOOD PRESSURE;
CLINICAL TRIALS;
ENALAPRIL;
FOLLOW-UP STUDIES;
HUMANS;
HYPERTENSION;
MIDDLE AGED;
PATIENT COMPLIANCE;
PILOT PROJECTS;
SWEDEN;
|
EID: 0033848976
PISSN: 00943509
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (6)
|
References (18)
|